Obesity and its management through Ayurveda

A CLINICAL EVALUATION OF METHI MODAK ALONG WITH UDVARTANA(KUTAJA BARK CHURNA)IN THE MANAGEMENT OF STHAULYA(OBESITY)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033172

Enrollment

Registered

2021-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Methi Modak Along with Udvartana(Kutaj Bark Churna): Methi Modak in the dose of 11 gm in two divided doses with Anupana of Sukh Ushna Jal for 45 days along with Udvartana(Kutaj Bark Chu

Eligibility

Inclusion criteria

Inclusion criteria: The patients between the age group of 18 to 70 years of either sex presenting with clinical features of Sthaulya (obesity). Patients having BMI above 25kg/m2.

Exclusion criteria

Exclusion criteria: Age below 18 and above 70 years. Patients with complicated and chronic disorders like Nephrotic syndrome, Hypothyroidism, Jaundice, Hepatitis, Chronic infections, and other serious diseases. The patient having BMI below 25. Patients having Obesity due to secondary causes such as drug-induced or hormonal imbalance like contraceptive pills. Pregnant women and lactating mothers. Patients suffering from Type 1 Diabetes mellitus and Type 2 Diabetes Mellitus & Uncontrolled Hypertension. Systemic illnesses like Tuberculosis, Carcinoma, and Endocrine disorders like Cushing syndrome, Hypothyroidism. The patient has a history of M.I. & Unstable Angina. Patient having Clinical Features of CCF. The patient having a major renal or liver disorder.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective parameters like ChalaSfikaUdarStana,Alasya,Kshudra shwasa, Dourbalya, Nidraahikya, Swedadikya,Dourgandha, Angagourav,Atipipasa, Ati ksudha, Alpavyavaya, alpa vyavaya, Gatrasad,Sandhishool, and objective parameter like Body Mass Index, site and level of body circumference measurement, skin fold thickness, Biochemical parameters like serum total cholesterol, serum triglyceride, Serum HDL, Serum LDL.Timepoint: At Base line and 6 weeks	—

Measure

Time frame

Improvement in subjective parameters like ChalaSfikaUdarStana,Alasya,Kshudra shwasa, Dourbalya, Nidraahikya, Swedadikya,Dourgandha, Angagourav,Atipipasa, Ati ksudha, Alpavyavaya, alpa vyavaya, Gatrasad,Sandhishool, and objective parameter like Body Mass Index, site and level of body circumference measurement, skin fold thickness, Biochemical parameters like serum total cholesterol, serum triglyceride, Serum HDL, Serum LDL.Timepoint: At Base line and 6 weeks

—

Secondary

Measure	Time frame
Efficacy will be accessed on the basis of the improvement in subjective and objective parameters.Timepoint: At baseline and 6 Weeks	—

Countries

India

Contacts

Public ContactDr lekha soni

DSRRAU Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026